TAM
LGND icon

THB Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History

THB Asset Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$2M Sell
32,214
-2,638
-8% -$150K 0.45% 79
2020
Q3 		$2.07M Buy
34,852
+2,218
+7% +$151K 0.57% 66
2020
Q2 		$2.28M Buy
+32,634
New +$2.07M 0.66% 62

Other funds holding LGND

William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $838M AUM 14.24% 1-Year Est. Return

THB Asset Management's LGND Position: Q4 2020 in Review

THB Asset Management reduced its Ligand Pharmaceuticals (LGND) stake by 7.6% in Q4 2020, selling an estimated $150K and leaving 32,214 shares worth $2M. The position accounts for 0.45% of the portfolio, ranked #79.

THB Asset Management first reported a position in LGND in Q2 2020 and has held it in 3 quarters since. The position peaked at $2.28M in Q2 2020. 242 funds tracked by Wall St. Rank hold LGND as of Q4 2020.

  • THB Asset Management held 32,214 shares of Ligand Pharmaceuticals worth $2M as of Q4 2020.
  • THB Asset Management sold 2,638 Ligand Pharmaceuticals shares in Q4 2020, an estimated $150K.
  • Ligand Pharmaceuticals made up 0.45% of THB Asset Management's portfolio in Q4 2020, its #79 holding.
  • THB Asset Management first reported a position in Ligand Pharmaceuticals in Q2 2020 and has held it in 3 quarters since.
  • THB Asset Management's Ligand Pharmaceuticals position peaked at $2.28M in Q2 2020.
  • 242 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2020.

Based on THB Asset Management's 13F filing for Q4 2020, filed 5 Feb 2021.